全球泌尿系統醫療設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計泌尿系統醫療設備市場將從 2025 年的 435.1 億美元成長到 2034 年的 843.4 億美元，2026 年至 2034 年的複合年成長率為 7.63%。

全球泌尿系統醫療設備市場持續穩定成長，反映出良性前列腺增生、腎結石、尿失禁和膀胱癌等泌尿系統疾病的發生率不斷上升。器械類別包括內視鏡、體外碎石系統、導尿管、支架和機器人輔助手術器械。由於微創手術的普及、診斷影像技術的進步以及篩檢率的提高，醫院、門診手術中心和診所對先進泌尿系統器械的需求日益成長。

市場的主要促進因素包括人口老化、前列腺和膀胱疾病發病率上升，以及雷射碎石術、一次性柔軟性輸尿管鏡和可降低感染風險的先進導管材料等技術創新。門診和日間手術模式的激增正在推動對攜帶式一次性醫療器材的需求。微創治療報銷體系的完善和早期診斷意識提升進一步促進了市場擴張，而監管機構對一次性醫療器材安全性的關注正在影響產品的設計和應用。

展望未來，創新預計將聚焦於機器人技術、影像引導療法和一次性醫療器械，以改善治療效果並降低感染風險。精準醫療方法，例如靶向膀胱內治療以及器械與藥物的聯合應用，或將湧現。新興市場的擴張和泌尿系統醫療服務可近性的提高也將促進市場逐步成長。能夠證明其產品具有臨床價值、成本效益和感染控制優勢的製造商，預計在未來十年內將佔據更穩固的市場地位。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球泌尿系統醫療設備市場：依產品類型分類

• 市場分析、洞察與預測
• 內視鏡
• 雷射和破碎設備
• 透析機
• 其他設備
• 配件

第5章 全球泌尿系統醫療設備市場：依應用領域分類

• 市場分析、洞察與預測
• 尿道結石
• 尿道惡性腫瘤
• 膀胱疾病
• 腎臟疾病
• 其他

第6章 全球泌尿系統醫療設備市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院及門診手術中心
• 透析中心
• 其他

第7章 全球泌尿系統醫療設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Boston Scientific Corporation
  • Coloplast A/S
  • Ethicon Inc（Johnson & Johnson）
  • Ambu A/S
  • Karl Storz SE & Co. KG
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthcare GmbH
  • Stryker Corporation
  • Cook Medical Inc
  • Dornier Medtech GmbH
  • Rocamed SA

The Urology Devices Market size is expected to reach USD 84.34 Billion in 2034 from USD 43.51 Billion (2025) growing at a CAGR of 7.63% during 2026-2034.

The global urology devices market has grown steadily, reflecting rising prevalence of urological disorders such as benign prostatic hyperplasia, kidney stones, urinary incontinence, and bladder cancer. Device categories include endoscopes, lithotripsy systems, catheters, stents, and robotic-assisted surgical tools. Minimally invasive procedures, improved diagnostic imaging, and greater screening rates have driven demand for advanced urology devices across hospitals, ambulatory surgery centers, and outpatient clinics.

Drivers include aging populations, higher incidence of prostate and bladder conditions, and technological innovations like laser lithotripsy, single-use flexible ureteroscopes, and advanced catheter materials that reduce infection risk. A surge in outpatient and day-surgery models favors portable and disposable devices. Reimbursement improvements for minimally invasive interventions and growing awareness around early diagnosis further support market expansion, while regulatory focus on single-use device safety influences product design and adoption.

Looking ahead, innovation will concentrate on robotics, image-guided therapies, and device disposability to enhance outcomes and reduce infection. Precision medicine approaches, including targeted intravesical therapies and device-drug combinations, may emerge. Expansion in emerging markets and greater access to urological care will contribute incremental growth. Manufacturers that can demonstrate clinical value, cost-effectiveness, and infection-control benefits will secure stronger market positions over the next decade.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Endoscopes
• Laser & Lithotripsy Devices
• Dialysis Devices
• Other Devices
• Accessories

By Application

• Urolithiasis
• Urethral Malignancies
• Bladder Disorders
• Kidney Diseases
• Others

By End-user

• Hospitals & Ambulatory Surgical Centers
• Dialysis Centers
• Others

COMPANIES PROFILED

• Boston Scientific Corporation, Coloplast AS, Ethicon Inc Johnson Johnson, Ambu AS, Karl Storz SE Co KG, Olympus Corporation, Richard Wolf GmbH, Siemens Healthcare GmbH, Stryker Corporation, Cook Medical Inc, Dornier Medtech GmbH, Rocamed SA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL UROLOGY DEVICES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Endoscopes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Laser & Lithotripsy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Dialysis Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL UROLOGY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Urolithiasis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Urethral Malignancies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Bladder Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Kidney Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL UROLOGY DEVICES MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals & Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Dialysis Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL UROLOGY DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL UROLOGY DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Boston Scientific Corporation
  • 9.2.2 Coloplast A/S
  • 9.2.3 Ethicon Inc (Johnson & Johnson)
  • 9.2.4 Ambu A/S
  • 9.2.5 Karl Storz SE & Co. KG
  • 9.2.6 Olympus Corporation
  • 9.2.7 Richard Wolf GmbH
  • 9.2.8 Siemens Healthcare GmbH
  • 9.2.9 Stryker Corporation
  • 9.2.10 Cook Medical Inc
  • 9.2.11 Dornier Medtech GmbH
  • 9.2.12 Rocamed SA